特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

TEL: 044-952-0102

ポイントオブケア診断の世界市場 - 成長率、動向および予測(2020年~2025年)

Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 660545
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
本日の銀行送金レート: 1USD=107.98円で換算しております。
ポイントオブケア診断の世界市場 - 成長率、動向および予測(2020年~2025年) Point-of-care Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年06月01日 ページ情報: 英文 114 Pages




第1章 イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 発展途上国における慢性疾患および感染症の罹患率の上昇
    • 新規イムノアッセイ技術に対する規制承認数の増加
    • 技術の進歩
    • 家庭用POCデバイスの使用の増加
  • 市場阻害要因
    • 大手企業による製品リコールが掻き立てる新規参入者の意欲
    • 厳格な規制方針と償還問題
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/買い手の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競合の激しさ

第5章 市場セグメンテーション

  • 製品別
    • グルコースモニタリングキット
    • 心代謝モニタリングキット
    • 妊娠・生殖能力検査キット
    • 感染症検査キット
    • コレステロールテストストリップ
    • 血液検査キット
    • その他の商品
  • エンドユーザー別
    • 病院/救命救急センター
    • 外来診療所
    • 研究所
    • 他のエンドユーザー
  • 地域
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott
    • Siemens AG
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • Instrumentation Laboratory
    • Johnson and Johnson
    • Nova Biomedical
    • Qiagen
    • F. Hoffmann-La Roche Ltd

第7章 市場機会および将来動向

Product Code: 55791

The point-of-care diagnostics market is expected to register a CAGR of 9.8%, over the forecast period. One of the major factors responsible for the growth of the market is the rising prevalence of chronic and infectious diseases in developing economies. The prevalence of chronic diseases, like diabetes, rheumatism, or cancer, is increasing globally, due to various reasons, such as an increase in the geriatric population, sedentary lifestyles, unhealthy food habits, and environmental factors. For instance, chronic diseases kill more than 38 million people each year, globally. Cardiovascular diseases account for most chronic disease deaths, or 17.5 million people, annually, followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). The aforementioned diseases account for 82% of all chronic disorder deaths. Point-of-care diagnostics is gaining wide acceptance by different patients across the world, as samples are collected from the patient's location for performing tests, and the results can be achieved in very less time, due to the use of micro fluids, chips, and nano diagnostics.

Factors, such as the increasing number of regulatory approvals for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices, are expected to drive the market growth, over the forecasted period.

Key Market Trends

Blood Glucose Testing is Expected to Hold Major Revenue Share in the Type of Product Segment

Blood glucose testing point-of-care diagnostics captured the largest share in 2019, due to the success of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose level is of vital importance for diabetic patients, which has encouraged the adoption of POC among diabetic patients in this segment. Other advantages associated with hand-held glucose meters are the portability and easy operability. The rising prevalence of diabetes across the world is expected to boost the segment growth in the future.

North America Dominates the Market and is Expected to do Same in the Forecast Period

Currently, North America dominates the market for point-of care-diagnostics, and is expected to continue its stronghold for a few more years. In the North America region, the United States holds the largest market share. This can be majorly attributed due to the growing geriatric population base in the country, as well as the factors, such as the increasing prevalence of diseases and the favorable government regulations and initiatives undertaken for the development of healthcare infrastructure.

Competitive Landscape

The point-of-care diagnostics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With rising prevalence of diseases and increasing number of aging population, other players are also expected to enter the market. Some of the major players of the market are Abbott, Siemens AG, Becton, Dickinson and Company, Johnson and Johnson, and F. Hoffmann-La Roche Ltd, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic and Infectious Diseases in Developing Economies
    • 4.2.2 Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques
    • 4.2.3 Technological Advancements
    • 4.2.4 Rising Usage of Home-based POC Devices
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls by Major Players Demotivate New Entrants
    • 4.3.2 Stringent Regulatory Policies and Reimbursement Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Glucose Monitoring Kit
    • 5.1.2 Cardio-metabolic Monitoring Kit
    • 5.1.3 Pregnancy and Fertility Testing Kit
    • 5.1.4 Infectious Disease Testing Kit
    • 5.1.5 Cholesterol Test Strip
    • 5.1.6 Hematology Testing Kit
    • 5.1.7 Other Products
  • 5.2 By End User
    • 5.2.1 Hospital/Critical Care Setting
    • 5.2.2 Ambulatory Care Setting
    • 5.2.3 Research Laboratory
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Siemens AG
    • 6.1.3 Beckman Coulter Inc.
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Instrumentation Laboratory
    • 6.1.6 Johnson and Johnson
    • 6.1.7 Nova Biomedical
    • 6.1.8 Qiagen
    • 6.1.9 F. Hoffmann-La Roche Ltd